Viral Vectors in Veterinary Vaccine Development

Viral Vectors in Veterinary Vaccine Development PDF Author: Thiru Vanniasinkam
Publisher: Springer Nature
ISBN: 3030519279
Category : Medical
Languages : en
Pages : 232

Get Book Here

Book Description
This highly accessible textbook introduces readers to the development of viral vectors and discusses their application in veterinary vaccinology. It offers comprehensive information on the latest advances in this emerging research field, together with a broad overview of the history of veterinary vaccines and viral vectors. The book also addresses issues concerning funding, translational research and ethics that will impact the future development, manufacture and global use of viral vector-based veterinary vaccines. The book addresses the needs of graduate students and researchers in the fields of Veterinary Medicine, Virology and Immunology. ​

Viral Vectors in Veterinary Vaccine Development

Viral Vectors in Veterinary Vaccine Development PDF Author: Thiru Vanniasinkam
Publisher: Springer Nature
ISBN: 3030519279
Category : Medical
Languages : en
Pages : 232

Get Book Here

Book Description
This highly accessible textbook introduces readers to the development of viral vectors and discusses their application in veterinary vaccinology. It offers comprehensive information on the latest advances in this emerging research field, together with a broad overview of the history of veterinary vaccines and viral vectors. The book also addresses issues concerning funding, translational research and ethics that will impact the future development, manufacture and global use of viral vector-based veterinary vaccines. The book addresses the needs of graduate students and researchers in the fields of Veterinary Medicine, Virology and Immunology. ​

Vaccines for Veterinarians

Vaccines for Veterinarians PDF Author: Ian R Tizard
Publisher: Elsevier Health Sciences
ISBN: 0323683002
Category : Medical
Languages : en
Pages : 361

Get Book Here

Book Description
**Selected for Doody’s Core Titles® 2024 in Veterinary Medicine** Both a theoretical text and a practical handbook, Vaccines for Veterinarians is the first of its kind to bring the basic science of animal vaccination and the practical details of vaccine use together in one single volume. From the first chapter on the history of vaccination and the triumph of rinderpest eradication to the last chapter on the rapidly emerging field of cancer vaccines, this book offers a truly comprehensive grounding in established and emerging vaccines for both major and minor species. Specific topics include viral vectored vaccines, DNA-plasmid vaccines, RNA vaccines, reverse vaccinology, the complexities of adjuvant use, vaccine failures and adverse events, vaccine production and regulation, robotic vaccination machines, contraceptive and production-enhancing vaccines, and so much more. At a time when resistance to human vaccination is receiving much publicity, this evidence-based book is the ideal counter to ill-informed speculation — serving as a timely reminder that vaccination is essential for the control of infectious diseases in animals. Well-respected and experienced veterinary author, Ian Tizard, provides expert guidance on the topic of vaccinations and immunology in veterinary medicine. Expert Consult site offers an online version of the book, making it easy to search the entire book electronically. The latest information on viral vectored vaccines keeps you up-to-date on the topic as well as the properties and relative advantages of currently used vectors in animal vaccines. Survey of vaccine responses covers the different mechanisms by which the immune system responds to different types of vaccines. Inclusion of the latest vaccine technologies discusses the advantages and disadvantages of DNA-plasmid vaccines, RNA vaccines, and more. Coverage of adverse events and hypersensitivities includes the best ways to treat them and report them. Coverage of passive immunization discusses the growing use of therapeutic monoclonal antibodies in veterinary medicine. Coverage of immunotherapy includes recent improvements and new products in both active and passive immunotherapy against animal cancers.

Vaccine Technologies for Veterinary Viral Diseases

Vaccine Technologies for Veterinary Viral Diseases PDF Author: Alejandro Brun
Publisher:
ISBN: 9781493930081
Category : Biomedicine
Languages : en
Pages : 265

Get Book Here

Book Description
This detailed volume explores the most popular antigen production and delivery strategies that have been tested in veterinary species. Viral vectors as well as genetic and protein subunit vaccines or large scale protein production systems are considered as well as an updated view of most options available for vaccine development, including the data obtained through experimental trials which contributes to the exploration and understanding of the immune mechanisms and immune correlates relevant in protection among different animal species. Written for the highly successful Methods in Molecular Biology series, chapters include brief introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and practical, Vaccine Technologies for Veterinary Viral Diseases: Methods and Protocols facilitates access to well-established protocols to those beginning in this interesting and laborious field as well as providing important basic knowledge when attempting a novel vaccine design or platform.

Novel Technologies for Vaccine Development

Novel Technologies for Vaccine Development PDF Author: Igor S Lukashevich
Publisher: Springer
ISBN: 3709118182
Category : Medical
Languages : en
Pages : 393

Get Book Here

Book Description
This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a “must read” for all those involved in vaccine development, both in academia and industrial vaccine development.

Veterinary Vaccines and Diagnostics

Veterinary Vaccines and Diagnostics PDF Author:
Publisher: Elsevier
ISBN: 0080526837
Category : Science
Languages : en
Pages : 875

Get Book Here

Book Description
This volume of Advances in Veterinary Medicine, derived in part from the First Veterinary Vaccines and Diagnostic Conferences, deals with vaccines, an especially active area of veterinary research and controversy.

Veterinary Vaccines

Veterinary Vaccines PDF Author: Samia Metwally
Publisher: John Wiley & Sons
ISBN: 1119506263
Category : Medical
Languages : en
Pages : 350

Get Book Here

Book Description
Provides a concise and authoritative reference on the use of vaccines against diseases of livestock Compiled by Senior Animal Health Officers at The Food and Agriculture Organization of the United Nations, and with contributions from international leading experts, Veterinary Vaccines: Principles and Applications is a concise and authoritative reference featuring easily readable reviews of the latest research in vaccinology and vaccine immune response to pathogens of major economic impact to livestock. It covers advice and recommendations for vaccine production, quality control, and effective vaccination schemes including vaccine selection, specifications, vaccination programs, vaccine handling in the field, application, failures, and assessment of herd protection. In addition, the book presents discussions on the current status and potential future developments of vaccines and vaccination against selected transboundary animal diseases. Provides a clear and comprehensive guide on using veterinary vaccines to protect livestock from diseases Teaches the principles of vaccinology and vaccine immune response Highlights the vaccine production schemes and standards for quality control testing Offers easy-to-read reviews of the most current research on the subject Gives readers advice and recommendations on which vaccination schemes are most effective Discusses the today’s state of vaccines and vaccination against selected transboundary animal diseases as well as possible future developments in the field Veterinary Vaccines: Principles and Applications is an important resource for veterinary practitioners, animal health department officials, vaccine scientists, and veterinary students. It will also be of interest to professional associations and NGO active in livestock industry.

Viral Vectors for Vaccine Development

Viral Vectors for Vaccine Development PDF Author: Qiana L. Matthews
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages :

Get Book Here

Book Description
Viral Vectors for Vaccine Development.

Approaches to Blocking the Immune Response to Gene Transfer with Viral Vectors

Approaches to Blocking the Immune Response to Gene Transfer with Viral Vectors PDF Author: Katherine High
Publisher: Frontiers E-books
ISBN: 2889190552
Category :
Languages : en
Pages : 96

Get Book Here

Book Description
Viral vectors are superior tools for gene therapy and as a genetic vaccine platform because viruses have evolved to efficiently infect and transfer their genomes to cells. Several impressive successes in viral vector-based gene therapies have been reported in humans, including restoration of vision in patients with Leber’s congenital amaurosis by retinal gene transfer and cures for severe immune deficiencies by gene transfer to hematopoietic stem cells. However, the mammalian immune system has evolved in parallel to fend off invading pathogens such as viruses. Innate and antigen-specific adaptive immune responses against viral vectors and therapeutic transgene products pose serious hurdles for successful gene therapy. Pre-existing immunity in humans, resulting from prior exposure to the parent virus that forms the basis for the gene transfer vehicle may be derived from, often prevents efficient gene transfer. This problem also reduces our ability to use certain vectors for genetic vaccination or in anti-cancer therapy. For these reasons, the gene transfer community has been extensively studying the mechanisms of immune responses against viral vectors and has started to develop strategies and protocols to block or circumvent such responses. Choice, design and engineering of a vector as well as the route of administration/target tissue can be optimized/ altered to minimize immune responses or evade pre-existing immunity. Immune suppression and modulation strategies are being developed in order to minimize inflammation, prevent antibody or T cell responses against vectors, and to promote tolerance to therapeutic gene products. Combinations of these approaches will likely facilitate clinical applications of gene therapy for many target diseases and also aid in vaccine development.

Vaccine Manual: The Production and Quality Control of Veterinary Vaccines for Use in Developing Countries

Vaccine Manual: The Production and Quality Control of Veterinary Vaccines for Use in Developing Countries PDF Author: Noel Mowat
Publisher: Daya Books
ISBN: 9788170352174
Category :
Languages : en
Pages : 452

Get Book Here

Book Description
In December 1991, at FAO Headquarters in Rome, the Animal Production and Health Division held an Expert Consultation in the Quality Control of Veterinary Vaccines in Developing Countries. The purpose of the consultation was to bring together experts in various aspects of vaccine production and quality control, to consider existing problems and likely future developments in the application of vaccines for the control of animal disease and to make recommendations in this important field. The consultation recommended that FAO lead the way in forging a closer cooperation among international organizations in the development of a more coherent approach to vaccine quality control; this manual is FAO s response to that recommendation. Written by some of the most highly regarded international experts in the field, the manual is principally concerned with providing guidelines and recommendations for the application of modern methods of vaccine production and evaluation, and also presents information on the state of veterinary vaccine development. Contents: Part I: Overview: The Present State of Veterinary Vaccine Development Chapter 1: The Introduction of Immunity by Veterinary Immunoprophylactics by W I Morrison, Chapter 2: Genetically Engineered Vaccines by B W J Mahy, Chapter 3: Viral Vaccines by F Brown, Chapter 4: Bacterial Vaccines by P D Walker, Chapter 5: Mycoplasmal Vaccines by A Provost, Chapter 6:Protozoal and Rickettsial Vaccines by A J DeVos, E Pipano, F Muissi and W K Jorgenesn, Chapter 7: Multicellular Parasite Vaccines by J B McKeand and D P Knox, Poultry Vaccines (1) Chapter 8: Conventional Vaccines by J B McFerran, Poultry Vaccines (2) Chapter 9: Special Requirements for Village Chickens by R P Spradbrow, Chapter 10: Fish Vaccines by A Adams, K D Thompson and R J Roberts, Chapter 11: Role of the Office International des Epizooties and International Organizations in Vaccine Quality Standardization by M Truszcynski and J Blancou. Part II: Planning and Management of Vaccine Production Chapter 12: Registration, Licensing, Controls and Practical Issues Related to Veterinary Vaccines by P Vannier, Chapter 13: The Role of Private Industry in the Transfer of Vaccine Tecnology to Developing Countries by A J B Haigh, Chapter 14: General Design and Operating Requirements for Vaccine Manufacturing Establishments by P J Radlett, Chapter 15: Design, Repair and Maintenance of Vaccine Manufacturing Establishments and Equipment by J Estefanell and L Mesopir, Chapter 16: Aspects of Financial Management of Vaccine Manufacturing Operations in Developing Countries by P deGreve, Chapter 17: The Logistics of Vaccine Manufacture in Developing Countries by P Hunter. Part III: Production Operations Chapter 18: Basic Laboratory Services and Media Preparation for Vaccine Production by E E Worrall, Chapter 19: Modern Cell Culture Technology for Vaccine Manufacture by P J Radlett, Chapter 20: Fermentation Technology for the Production of Bacterial Vaccines by F Bover, Chapter 21: The Use of Lyophilization in the Manufacture of Vaccines by J C Mariner, Inactivation of Antigents for Veterinary Vaccines (1) Chapter 22: Viral Vaccines by H G Bahnemann, Inactivation of Antigents for Veterinary Vaccines (2) Chapter 23: Bacterial Vaccines, Chapter 24: Adjuvants in Veterinary Vaccines by R Bomford, Chapter 25: Bottling, Labelling and Packaging of Vaccines by V A Srinivasan, A P Kariath and P B V P Bangar Raju. Part IV: Quality Assurance and Quality Control Chapter 26: Quality Assurance and Good Manufacturing Practice by J P Soulebot, V J Palya, M Rweyemamu and D Sylla, Chapter 27: The Principles of Good Laboratory Practices, Including Safety in Vaccines Production and Quality Control by C A Mebus, Chapter 28: The Role of Reference and Regional Laboratories by A I Donaldson and V Astudillo, Chapter 29: Description and Documentation of Production and Quality Control of Veterinary Vaccines by S Ullah and G Blocks, Chapter 30: Assessment of Potency in Bacterial Vaccines by P A Knight, Chapter 31: Potency Control of Modified Live Viral Vaccines by C Terpstra, Chapter 32: Potency Assessment of Inactivated Viral Vaccines by T R Doel, Chapter 33: In Vitro Potency Testing of Inactivated Biologics: Current Situation in the European Union by J P Soulebot, F Milward and P Prevost, Chapter 34: Sterility Management and Testing of Vaccines and Raw Materials for Adventitious Agents by G Blocks.

Process Development for Production of Newcastle Disease Virus-vectored Vaccines Using Suspension Vero Cells

Process Development for Production of Newcastle Disease Virus-vectored Vaccines Using Suspension Vero Cells PDF Author: Julia Puppin Chaves Fulber
Publisher:
ISBN:
Category :
Languages : en
Pages : 0

Get Book Here

Book Description
"As seen with the devastating COVID-19 pandemic, infectious diseases remain a global concern. Consequently, there have been many efforts placed on preparing for pandemics and developing vaccine platforms. Viral vectored vaccines are especially promising, having been approved for use against Ebola and SARS-CoV-2. In this category, the Newcastle Disease Virus (NDV) is an avian virus which shows great potential as a viral vector for veterinary and human vaccines. Currently, NDV is mostly produced in embryonated chicken eggs, which lack the control over parameters and scalability that production in cell culture can offer. As such, this work sets out to establish the basis for producing NDV using suspension Vero cells, therefore contributing to the important field of vaccine manufacturing by improving the scalability of NDV production and expanding the toolbox of viral vectors available to the market.NDV has prominent applications for oncolytic therapy and vaccination. We highlight its potential as a viral vector by reviewing the advantages of NDV as a platform for vaccines and compiling the pre-clinical and clinical studies for human and veterinary vaccines using NDV as a vector. Importantly, our literature review identifies the gap in data for NDV manufacturing, pointing towards the necessity of process development studies. We also draw comparisons to progress achieved in the production of similar viral vectors, laying out a roadmap for what could be done for NDV and, ultimately, identifying process intensification as an important aspect.Aiming to fill this gap on NDV research, we adapt this virus to production in suspension cell culture, using the HEK293 and Vero cell lines. We use viral constructs that contain green fluorescent protein (NDV-GFP) or full-length SARS-CoV-2 Spike protein (NDV-FLS) as models to evaluate upstream parameters for viral production, including multiplicity of infection (MOI), temperature, trypsin concentration and time of harvest. On the analytical level, we develop a tissue culture infectious dose 50% assay (TCID50) and a digital droplet polymerase chain reaction assay (ddPCR), which quantify infectious and total viral particles, respectively. We apply these efforts to 1 L batch bioreactor runs, demonstrating the feasibility of the bioprocesses that were developed.In conclusion, this work advances the field of vaccine bioprocessing, which is critical in responding to and preventing pandemics. We establish key aspects of a production process for NDV and elucidate the next steps required to consolidate this viral vector as a vaccine platform, so that it can quickly be adapted to target emerging viruses"--